Controversial Toxicology Protocol Is “Getting The Information We Need;” Additionally Revision Made
In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials
DCT Board Sends Message On Cutting Grants to Extend Paylines, Then Tries To Take It Back
St. Jude Offers Three Fellowships
NCI Test Panels Available For Marker Evaluation
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
- The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community